Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Apr 2016 07:00

RNS Number : 1282V
Premaitha Health PLC
14 April 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

PREMAITHA HEALTH PLC

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation:

HARGREAVE HALE LIMITED

4. Full name of shareholder(s) (if different from 3.):

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached:

12 APRIL 2016

6. Date on which issuer notified:

13 APRIL 2016

7. Threshold(s) that is/are crossed orreached:

5%

     
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

Direct

Indirect

 

GB00BN31ZD89

10,581,665

10,581,665

 

18,331,665

 

18,331,665

 

 

8.0344%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

18,331,665

8.0344%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

12,560,000 of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the investments on a discretionary basis. The remaining shares are held for other discretionary clients.

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

 

14. Contact name:

David Clueit

Hargreave Hale Ltd

15. Contact telephone number:

01253 754739

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOVVRNBASAAR
Date   Source Headline
24th Sep 20078:00 amRNSDirectorate Change
23rd Aug 200711:11 amRNSAdditional Listing
20th Aug 20077:00 amRNSAIM Rule 26
6th Aug 20077:00 amRNSSigns MOU with Taiwan ITRI
20th Jul 200712:21 pmRNSDirectorate Change
13th Jul 200711:58 amRNSDirectorate Change
19th Jun 20077:01 amRNSIssue of Equity
5th Jun 20073:00 pmRNSTechnology Update
30th Apr 200711:07 amRNSCisco purchases SPM Product
30th Apr 20077:49 amRNSBusiness update
18th Apr 20075:33 pmRNSDirector/PDMR Shareholding
18th Apr 20077:01 amRNSDirectorate Change
5th Apr 200710:18 amRNSTechnology Update
28th Mar 20077:02 amRNSLicensing agreement
16th Jan 200712:46 pmRNSHolding(s) in Company
5th Jan 20077:53 amRNSTechnology Update
4th Jan 20077:00 amRNSMilestone Achieved
15th Dec 20065:10 pmRNSTotal Voting Rights
5th Dec 20064:47 pmRNSHolding(s) in Company
1st Dec 200611:28 amRNSInterim Results
30th Oct 20065:18 pmRNSChange of Name
27th Oct 20063:56 pmRNSSch 1 Update- Original Invest
26th Oct 20063:11 pmRNSAGM Statement
6th Oct 20064:28 pmRNSSchedule 1 - Original Invest
27th Sep 200610:30 amRNSAcquisition
27th Sep 200610:30 amRNSFinal Results
11th Sep 20069:02 amRNSDirectorate Change
18th Jul 200612:52 pmRNSHolding(s) in Company
25th Apr 20067:01 amRNSTrading Statement
8th Feb 20063:11 pmRNSHolding(s) in Company
21st Dec 20057:00 amRNSInterim Results
30th Nov 20057:04 amRNSTrading Statement
18th Nov 20057:00 amRNSProduct Launch
29th Sep 200510:07 amRNSResult of AGM, change of name
5th Sep 20057:00 amRNSViaLogy Trading Update
16th Aug 20055:51 pmRNSFinal Results
16th Aug 20057:00 amRNSFinal Results
1st Jun 20053:18 pmRNSDirector Shareholding
25th Jan 20053:17 pmRNSDirector Shareholding
17th Jan 20052:28 pmRNSTrading Statement
5th Jan 20057:00 amRNSDisposal of Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.